Flex helps our customers anticipate and meet power requirements driven by long-term energy transitions. We do so by leveraging our extensive cross-industry expertise to create capabilities and ...

Agonists for TLR4, TLR7, TLR8 and TLR9 are being tested as adjuvants for infectious diseases and in certain cancers. There is also potential for some of these agents in the de-sensitization of ...